BIZENGRI FDA approval date

The FDA approved BIZENGRI on 4 Dec 2024.

FDA approval date
4 Dec 2024

Drug identity has not yet been verified against registry records

Also recorded as ZENOCUTUZUMAB-ZBCO

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-12-04DayBIZENGRIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761352", "applicant_as_listed_by_fda": "MERUS N.V.", "brand_names": ["BIZENGRI"], "active_ingredients": ["ZENOCUTUZUMAB-ZBCO"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20241204", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026